Biogen Pharmachem Industries fundamental analysis

BIOGEN

0.7

0.02 (-2.78%)
Last updated on 30 Dec, 2025 | 15:53 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Biogen Pharmachem Industries Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

46.92

Sector P/B

2.74

Sec. Div. Yield

88.78

Biogen Pharmachem Industries Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 46.92. Its P/B Ratio stands at 0, while the sector’s is 2.74. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 88.78%.

Biogen Pharmachem Industries Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Poor

On its scorecard, Biogen Pharmachem Industries reflects: Price – Expensive, Growth – Poor, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.